Examining FDA's Role in the Regulation of Genetically Modified Food Ingredients | Energy & Commerce Committee

Examining FDA's Role in the Regulation of Genetically Modified Food Ingredients | Energy & Commerce Committee:

Background Documents and Information: 

Hearing Notice

Background Memo

H.R. 4432, To amend the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism,the labeling of natural foods, and for other purposes.

Opening Statements: 

Health Subcommittee Chairman Joseph R. Pitts

Witnesses: 

Panel I

Michael M. Landa

• Director, Center for Food Safety and Applied Nutrition
• U.S. Food and Drug Administration
• Witness Testimony (Truth in Testimony and CV)

Panel II

Alison Van Eenennaam, PhD

• Cooperative Extension Specialist
• Animal Genomics and Biotechnology, Department of Animal Science
• University of California, Davis
• Witness Testimony and Supplemental Material (Truth in Testimony and CV)

Scott Faber

• Senior Vice President of Government Affairs
• Environmental Working Group
• Witness Testimony (Truth in Testimony and CV)

Rep. Kate Webb

• Assistant Majority Leader
• Vermont House of Representatives
• Witness Testimony (Truth in Testimony and CV)

Stacey Forshee

• Fifth District Director
• Kansas Farm Bureau
• Witness Testimony (Truth in Testimony and CV)

Tom Dempsey

• President and CEO
• Snack Food Association
• Witness Testimony (Truth in Testimony and CV)

Congress: 

113th

The transcript of HR 4432 will be available here (GPO can take 90 days - 202/512-1800)